viernes, 11 de enero de 2019

Eli Lilly to buy Loxo Oncology for $8 billion in huge bet on cancer genetics

Eli Lilly to buy Loxo Oncology for $8 billion in huge bet on cancer genetics

Daily Recap

Eli Lilly to buy Loxo Oncology for $8 billion in huge bet on cancer genetics

By MATTHEW HERPER


ANNE WESTON/FRANCIS CRICK INSTITUTE
The pharmaceutical giant will purchase Loxo Oncology, a tiny startup, for $8 billion in cash to gain access to the company’s cancer medicines.

No hay comentarios: